← Eichor
Study identifier: NCT06738953 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

Prevention of Mental Disorders Through Self-efficacy Interventions

Condition: Depression Disorders · Affective Disorders · Prevention  ·  Sponsor: Health and Medical University Potsdam

PhaseNA
Planned participants378
Who can joinAll sexes, 18 Years to 30 Years
Healthy volunteersYes

About this study

Low self-efficacy is a transdiagnostic risk factor for several mental disorders. Self-efficacy refers to one's belief that one is capable of performing a behavior necessary to successfully complete a task or achieve a goal. Consistent with theoretical models and empirical findings, individuals with low self-efficacy are more likely to perceive challenges as uncontrollable and threatening and thus are at increased risk for developing mental disorders during sensitive periods such as young adulthood. Self-efficacy interventions have been shown to be effective in promoting health behavior change, quality of life, and treatment adherence in patients with serious illnesses, as well as motivation and performance in students and employees. However, whether targeted self-efficacy training can prospectively prevent the onset of full-threshold anxiety, affective, and substance use disorders in young adults at increased risk for psychopathology remains an open question. The aim of this randomized controlled trial is to test whether a brief cognitive-behavioral intervention in young adults with low self-efficacy can increase general self-efficacy (primary outcome of intervention effectiveness) and thus prevent the onset of DSM-5 mental disorders in the subsequent year (primary outcome of prevention effectiveness). In addition, we examine whether improvements in domain-specific self-efficacy lead to subsequent improvements in general self-efficacy and thus to lower psychopathological sym…

This description comes directly from the study's public registry record.

Talk to the study team

Eva Asselmann, Prof. Dr. rer. nat. habil.  ·  +49 331 74 51 13 131  ·  eva.asselmann@health-and-medical-university.de

Felix D Gross, M. Sc. Psychology  ·  +49 331 74 51 13 131  ·  felix.gross@hmu-potsdam.de

Always discuss trial participation with your own doctor first.

Locations (1)

Health and Medical University PotsdamPotsdam, Brandenburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06738953